Krystal Biotech, Inc. KRYS Other Non-Current Liabilities
Other Non-Current Liabilities at other companies
Other financials
Where this comes from
Reported directly by Krystal Biotech, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OtherLiabilitiesNoncurrent.
The official record: Krystal Biotech, Inc.’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →
Ask your AI about Krystal Biotech, Inc.'s other non-current liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Krystal Biotech, Inc.'s other non-current liabilities?
- Krystal Biotech, Inc. (KRYS) reported other non-current liabilities of $5.12M in Q1 2026.
- How has Krystal Biotech, Inc.'s other non-current liabilities changed year-over-year?
- Krystal Biotech, Inc.'s other non-current liabilities increased by 162.4% year-over-year, from $1.95M to $5.12M.
- What does other non-current liabilities mean?
- Miscellaneous long-term debts or obligations not categorized elsewhere.
- How do you interpret other non-current liabilities?
- Significant changes should be investigated via footnotes, as they may represent unique long-term contractual obligations or changes in accounting estimates.
- How does other non-current liabilities compare across companies?
- Varies by company; usually a small portion of the balance sheet unless specific long-term liabilities exist.